A detailed history of High Tower Advisors, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 19,572 shares of CRMD stock, worth $194,937. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,572
Previous 19,138 2.27%
Holding current value
$194,937
Previous $82,000 92.68%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.64 - $8.23 $1,579 - $3,571
434 Added 2.27%
19,572 $158,000
Q3 2023

Nov 08, 2023

SELL
$3.6 - $4.46 $62,100 - $76,935
-17,250 Reduced 47.41%
19,138 $70,000
Q2 2023

Aug 14, 2023

BUY
$3.94 - $5.8 $67,965 - $100,050
17,250 Added 90.13%
36,388 $144,000
Q2 2022

Aug 10, 2022

BUY
$2.73 - $5.61 $13,650 - $28,050
5,000 Added 35.37%
19,138 $77,000
Q1 2022

May 12, 2022

SELL
$3.83 - $6.24 $5,745 - $9,360
-1,500 Reduced 9.59%
14,138 $78,000
Q4 2021

Feb 10, 2022

BUY
$4.47 - $5.56 $6,705 - $8,340
1,500 Added 10.61%
15,638 $72,000
Q1 2021

May 10, 2021

SELL
$6.84 - $17.58 $15,048 - $38,675
-2,200 Reduced 13.47%
14,138 $141,000
Q4 2020

Feb 10, 2021

BUY
$5.0 - $9.15 $81,690 - $149,492
16,338 New
16,338 $121,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $410M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.